Latigo Biotherapeutics, Inc.
Public company- Headquarters
- THOUSAND OAKS, California
- Ticker
- LTGO
- CIK
- 0002056611
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
3
1 appointment, 2 departures
Last event
Nov 5, 2026
Executive appointmentCEO appointed: Todd Smith
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOTodd Smith | Nov 5, 2026 | Appointed |
| member of the BoardNima Farzan | Nov 5, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
No events of this type on record.
Show all eventsLast verified Nov 8, 2026